The Importance of Stool Occult Blood Tests in Getting to 80% Durado Brooks, MD, MPH Director, Cancer Control Interventions American Cancer Society.

Slides:



Advertisements
Similar presentations
Colon and Rectal Cancer Update
Advertisements

Organized colorectal cancer screening program with FOBT: participation and diagnostic yield deteriorate with time Results – yield Aim To assess the short.
Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Sex Differences in the Prevalence and Correlates of Colorectal Cancer Testing: Health Information National Trends Survey Sally W. Vernon 1, Amy.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Colon-Rectal Cancer Keith Bradley, MD National Alliance of Research Associates Programs NARAP.
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Haley Hyde Jessica Fordham Jena Hamm  Colorectal cancer is a leading cause of cancer related deaths every year.  150,000 Americans will be diagnosed.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Integrated Cancer Screening Colorectal Cancer Screening.
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
D EPARTMENT of F AMILY M EDICINE Colon Cancer Screening in Iowa Barcey T. Levy, PhD, MD Professor, Family Medicine and Epidemiology University of Iowa.
Expanding CRC screening: Understanding the options and the costs to providers Paul Brown Kelly Kohler University of North Carolina 1.
Turning Data into Action for Colorectal Cancer November 17, 2014 Jessica Shaffer, Director, Maine CDC Colorectal Cancer Control Program
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Mobilizing Newcomers and Immigrants to Cancer Screening Programs funded by Public Health Agency of Canada (PHAC) The views expressed herein do not necessarily.
Implementation of an evidence-based cancer screening program for an urban disabled population Ryan Goetz BSCh Lewis Cancer & Research Pavilion at St. Joseph’s/
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
The Value of Partnerships: Advancing Our Efforts Through Collaboration ICC Cancer Summit October 3-4, 2011 Lorrie Graaf, American Cancer Society Bobbie.
Colorectal Cancer (CRC) Surveillance: Introduction and Overview Carrie Klabunde, Ph.D. IBSN Biennial Meeting Ottawa, Canada May 11-12, 2006.
Improving Colon Cancer Screening Rates July 31, 2013.
Improving Preventive Health Care Success Stories: USPSTF and ePSS at San Francisco General Hospital AHRQ 2009 Conference Alice Hm Chen, MD, MPH.
1 Colorectal Cancer # 2 Cancer Killer # 2 Cancer Killer SCREENING SAVES LIVES.
Colon Cancer Screening for Primary Care Physicians Richard C. Wender, MD Alumni Professor and Chair Department of Family & Community Medicine Thomas Jefferson.
Colorectal Cancer Screening in Appalachia PA: a pilot intervention project William Curry, MD, MS Dept of Family & Community Medicine M.S.Hershey Medical.
Flu-FOBT Pilot Project October 2013 Marla Jackson (ESC) & Cheryl Shoemaker (WW) July 14, 2014.
The FluFIT Program: Leveraging Flu Shot Campaigns to Promote Colorectal Cancer Screening October 11, 2013.
80% by 2018: Increasing Colon Cancer Screening in Community Health Centers Richard C. Wender, MD Chief Cancer Control Officer American Cancer Society,
The Importance of Stool Occult Blood Tests in Getting to 80% Durado Brooks, MD, MPH Director, Cancer Control Interventions American Cancer Society, Inc.
VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.
Finding non-traditional allies for CRC screening Gloria D. Coronado, PhD Beverly B. Green, MD, MPH Policy- makers Community Partners Clinic staffPatients.
Steps for Increasing Colorectal Cancer Screening Rates: A Manual for Community Health Centers Maria Syl D. de la Cruz, MD Assistant Professor, Department.
Assessing Colorectal Cancer Screening in Appalachia PA William Curry, MD, MS Mark Dignan, PhD Gene Lengerich, VMD Alan Adelman, MD, MS.
“Action Plan” Guide for Increasing Tobacco Cessation Referrals Leigh Anne Hehr Manager, State-Based Health Systems, Ohio American Cancer Society.
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
80% by 2018: Getting FIT to Reach Our Goal Richard C. Wender, MD Chief Cancer Control Officer American Cancer Society, Inc. 1.
Factors Predicting Stage of Adoption for Fecal Occult Blood Testing and Colonoscopy among Non-Adherent African Americans Hsiao-Lan Wang, PhD, RN, CMSRN,
Recommendations for Preventing Cancer and Finding It Early: Prostate and Colorectal UCAN Conference May 14, 2015 Durado Brooks, MD, MPH Director, Prostate.
D EPARTMENT of F AMILY M EDICINE Colorectal Cancer Screening: Update on Guidelines and Projects Barcey T. Levy, PhD, MD Professor, Department of Family.
Enhancing Colorectal Cancer Awareness and Screening Rates Jason P Crawford, MD, MPH Saturday, 3/8/16.
Presented by: Liz M. Baker, CHES NC Comprehensive Cancer Program 1.
Jason P Crawford, MD, MPH Saturday, 3/8/16 Enhancing Colorectal Cancer Awareness and Screening Rates.
Developing an Effective Ambulatory Care Process to Improve Rates of Colorectal Cancer Screening Shabana Farooq MD,FAAFP April 27, 2015.
Medical Advisory Board Quality assurance Maine Cancer Registry US Centers for Disease Control and Prevention Cancer Treatment Centers and Cancer Treating.
Colorectal Cancer: Education and Screening in a Rural Community Grinnell Regional Public Health.
1 Evidence based health SCREENING Dr.Hathaitip Tumviriyakul Diploma Family medicine,Hatyai Hospital Msc. Epidemiology LSHTM,UK.
1234 “FIT” IT IN! Make time to ensure your patients get screened for colon cancer.
Date of download: 7/1/2016 From: Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task.
USPSTF Colorectal Cancer Screening Guidelines: What’s New?
Colorectal Cancer Screening Guidelines
What you need to know about the Fecal Occult Blood Test
WellOne Primary Medical and Dental Care
A Cost Containment Project
Different Tests to Detect Colonic Polyps
Increasing Access to Colorectal Cancer (CRC) Screening in Rural East Texas where there is a High rate of Adenomatous Polyps Detected Carlton Allen, MS,
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Increasing Access to Colorectal Cancer Screening in Rural East Texas
Cancer screening PROF .MAZIN AL-HAWAZ.
WellOne Primary Medical and Dental Care
Evaluation of a Spiritually-based Intervention to Increase Colorectal Cancer Knowledge and Screening Among Church-attending African Americans and Whites.
SAMPLE – Preliminary Results
Patient Experience: CRC Screening
Developing a Health Maintenance Schedule
Colon Alert: Providers Need Reminders Too August 23, 2017
Essential Concepts in the Screening and Detection of Colorectal Cancer
Therese Chan Tack, DO MPH Improving Colorectal Cancer Screening among PRIME population in Primary Care.
Citation: Cancer Care Ontario
The Research Question Flexible sigmoidoscopy (FS) is the only cancer screening modality (for any type of cancer) to reduce all-cause mortality compared.
BeneFIT SIP: A Pilot Program of Mailed FIT Tests to Increase Colorectal Cancer Screening Rates in Medicaid / Medicare health plans.
American Cancer Society Guidelines for the Early Detection of Cancer
Presentation transcript:

The Importance of Stool Occult Blood Tests in Getting to 80% Durado Brooks, MD, MPH Director, Cancer Control Interventions American Cancer Society

Stool Occult Blood Tests Look for hidden blood in stool. Two major types –Guaiac –Immunochemical (FIT) Multiple brands (all are not created equal)

Efficacy

Accuracy

6

7

Preferences

Patient Preferences Inadomi, Arch Intern Med 2012

Many Patients Prefer Stool Tests  Diverse sample of 323 adults given detailed side-by-side description of FOBT and colonoscopy (DeBourcy et al. 2007)  53% preferred FOBT  Almost half felt very strongly about their preference  212 patients at 4 health centers rated different screening options with different attributes (Hawley et al. 2008)  37% preferred colonoscopy  31% preferred FOBT  Nationally representative sample of 2068 VA patients given brief descriptions of each screening mode (Powell et al. 2009)  37% preferred colonoscopy  29% preferred FOBT

Quality

Stool Testing Quality Issues In-office FOBT is essentially worthless as a screening tool for CRC and should never be used. CRC screening by FOBT should be performed with high-sensitivity FOBT - either FIT or a highly sensitive gFOBT (such as Hemoccult SENSA). – Older, less sensitive guiaic tests (such as Hemoccult II) should not be used for CRC screening. Annual testing All positive screening tests should be evaluated by colonoscopy

Clinicians Reference: FOBT One page document designed to educate clinicians about important elements of colorectal cancer screening using fecal occult blood tests (FOBT). Provides state-of-the-science information about guaiac and immunochemical FOBT, test performance and characteristics of high quality screening programs. Available at High Quality Stool Testing

Evidence Based Interventions

 Standing orders  Patient reminders  Mailed outreach  FluFIT/FluFOBT

What is a FluFIT program?  Takes advantage of patient awareness and desire for annual flu shots by using existing outreach and in-reach efforts to offer CRC screening.  Practice staff recommend CRC screening and provide FOBT kits to eligible patients when they get their annual flu shot  Either a high sensitivity FOBT or a FIT can be used  Patient completes FOBT at home and returns kit to doctor’s office or mails kit to the lab for processing

CRC Screening Outreach During Annual Flu Shot Activities  Potential Benefits of “Flu-FOBT” or “Flu-FIT” Programs:  Reaches patients at a time each year when they are already thinking about prevention  Creates a seasonal focus on cancer screening that may add to other screening efforts  Time-efficient way to involve non-physician staff in screening activities  Educates patients that “just like a flu shot, you need FOBT/FIT every year” Slide courtesy of M. Potter, MD

Stool Occult Blood Testing Health systems must: Understand the importance of providing patients with screening options Educate clinicians Pick a high sensitivity guaiac or FIT Ensure that stool testing programs address important quality elements